A Combined Approach for Improving Cardiopulmonary Bypass in Coronary Artery Surgery: A Pilot Ptudy
Abstract: Background: This is a pilot study carried out to assess the feasibility and the clinical impact of a combined approach of […]
World's Largest Resource for Cardiovascular Perfusion
Abstract: Background: This is a pilot study carried out to assess the feasibility and the clinical impact of a combined approach of […]
As anticipated, COVID-19 is a pandemic; all healthcare resources are stretched so that ECMO is not a therapy to be rushed to the frontline. Therefore, interim treatment guidelines of recommending ECMO for critically ill COVID-19 patients should be taken cautiously.
Profound CS was associated with high mortality. Both successful weaning from ECMO and an APACHE II score might serve as outcome predictors for risk stratification.